Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

Objective: The addition of androgen deprivation therapy (ADT) to conventional radiation therapy improves overall survival (OS) in intermediate- and high-risk prostate cancer. The benefit of ADT to added to dose-escalated radiotherapy is less clear. The aim of this study was to report disease control...

Full description

Bibliographic Details
Main Authors: Rafael Gadia, MD, Elton Trigo Teixeira Leite, MD, Ana Luiza Bierrenbach, PhD, Fabio Ynoe de Moraes, MD, Daniel E. Spratt, MD, Fernando Freire Arruda, MD, Carlos Eduardo Cintra Vita Abreu, MD, Joao Luis Fernandes da Silva, MD, Heloisa de Andrade Carvalho, PhD, Bernardo Garicochea, PhD
Format: Article
Language:English
Published: Elsevier 2016-10-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109416300604

Internet

http://www.sciencedirect.com/science/article/pii/S2452109416300604

Similar Items